City of Champions

City of Champions is an occasion to network with local dignitaries and an excellent opportunity to enjoy friendly competition, a beautiful day on the links, and incredible hospitality at Wellesley Country Club.

City of Champions is an occasion to network with local dignitaries and an excellent opportunity to enjoy friendly competition, a beautiful day on the links, and incredible hospitality at Wellesley Country Club.

KEYNOTE ADDRESSMichael MilkenFounder and ChairmanProstate Cancer Foundation Introduced by Stuart Holden (Prostate Cancer Foundation, University of California, Los Angeles) View the Transcript Below: Keynote Address Michael Milken [00:00:04] In looking at who’s here, there’s two or three themes which I’d…

SPECIAL LECTURE: CEO’s AddressGina Carithers (Prostate Cancer Foundation) Introduction by Howard Soule (Prostate Cancer Foundation) View the Transcript Below: CEO’s Address Howard Soule, PhD [00:00:17] It’s now my real pleasure to introduce our PCF president and chief executive officer, Gina…

SESSION 1: Theranostics: New Targets, New AtomsModerator:Michael Hofman (Peter MacCallum Cancer Centre) Prostate Cancer Theranostics: What’s Hot in 2025?Michael Hofman (Peter MacCallum Cancer Centre) Terbium-161 PSMA: Does Auger Strike a Perfect Balance of Beta and Alpha?James Buteau (Peter MacCallum Cancer…

SESSION 2: Immunotherapy for Prostate CancerModerator: Nour Shobaki (University of Pennsylvania) Pasritamig, a Differentiated, KLK2-Targeted T Cell Engager for Prostate CancerCharles Drake (Johnson & Johnson Innovative Medicine) View the Transcript Below: Immunotherapy for Prostate Cancer Nour Shobaki, PharmD, PhD [00:00:12]…

Session 3: Drugging the Epigenome to Target Lethal DiseaseModerators: Amina Zoubeidi (Vancouver Prostate Centre) Michael Shen (Columbia University) The Landscape of N6-Metyladenosine in Localized Primary Prostate Cancer and how these Modifications can Drive Disease AggressivenessHousheng Hansen He (Princess Margaret Cancer…

SESSION 4: Updates from Industry Clinical TrialsModerator: Howard Soule (Prostate Cancer Foundation) PSMAddition: Initial Results from the Phase III Trial of Lu-177-PSMA-617 in Metastatic Hormone Sensitive Metastatic Prostate CancerOliver Sartor (Tulane University) A Phase 3 Stude of Capivasertib + Abiraterone…

SESSION 5: Artificial Intelligence and Machine Learning to Better Inform Patient OutcomesModerator: Tamara Lotan (Johns Hopkins University) Pathology Deep Learning Tools for Localized Prostate CancerTamara Lotan (Johns Hopkins University) Navigating the Prostate Cancer Journey with Genetic Testing, RNA, AI, and…

SESSION 6: Novel Technology for Circulating Biomarker DevelopmentModerators:Himisha Beltran (Dana-Farber Cancer Institute)Alexander Wyatt (University of British Columbia) PC-SYNERGY: Biological and Therapeutic Insights from a Metastatic Prostate Cancer Atlas at Single Cell Resolution (TACTICAL AWARD)Peter Nelson (Fred Hutchinson Cancer Center) Circulating…

SESSION 7: Emerging Roles and Strategies to Harness the Host Microbiome in CancerModerator: Karen Sfanos (Johns Hopkins University) The Role of the Microbiome in Host Androgen Production and Therapeutic Resistance in CRPCKaren Sfanos (Johns Hopkins University) Gut Reactions: How the…

SESSION 8: Exercise Interventions for Patients with Prostate Cancer Moderators: June Chan (University of California, San Fracisco)Christina Dieli-Conwright (Harvard: Dana-Farber Cancer Institute) Better Together: The Benefits of Team-based Exercise for Couples Coping with Prostate CancerKerri Winters-Stone (Oregon Health & Science…

SESSION 9: AI-Driven Precision Medicine/R&D Efforts in Academia and BioPharma Moderator & Introduction: Marco Gottardis (Gottardisbiotech LLC) Generative AI for the Development of Novel Cancer TherapeuticsAlex Therien (Generate Biomedicines) Picking Pockets in the Disordered Androgen Receptor N-TerminalAndrew Allen (Peptone) View…

SPECIAL LECTURE: How Does Androgen Biosynthesis Occur Independent of CYP17A1 and CYP11A1? Nima Sharifi (University of Miami) Introduction by Howard Soule (Prostate Cancer Foundation) View the Transcript Below: How Does Androgen Biosynthesis Occur Independent of CYP17A1 and CYP11A1 Howard Soule,…

SPECIAL LECTURE: Early Interception: Integrating Tissue-Based Insights to Optimize ARPi+PARPi Combination Therapy in HSPCPatrick Pilié (University of Texas MD Anderson Cancer Center) Introduction by Christopher Logothetis (University of Texas MD Anderson Cancer Center) View the Transcript Below: Early Interception Integrating…

PCF Women in Science Lifetime Achievement Award Lecture: From Mesopotamia to the Great Lakes “The 6000 Miles Journey”: Prostate Cancer Then & NowMaha Hussain (Northwestern University) Introduction by Andrea Miyahira (Prostate Cancer Foundation) View the Transcript Below: From Mesopotamia to…

Dr. Felix Feng Legacy Lecture: The Ongoing Legacy of Felix Feng Team ScienceDaniel Spratt (Case Western University) Introduction by Howard Soule (Prostate Cancer Foundation) View the Transcript Below: The Ongoing Legacy of Felix Feng Team Science Howard Soule, PhD [00:00:12]…

MYC Family MattersMyles Brown (Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute) View the Transcript Below: MYC Family Matters Himisha Beltran, MD [00:00:13] Hello, everyone. It is my great pleasure to introduce my colleague and friend, Dr. Myles Brown. Dr.…

SPECIAL LECTURE: From Bench to Business: Bridging Biomedical Research and Entrepreneurial Drug DevelopmentArie Belldegrun (University of California, Los Angeles) Introduction by Stuart Holden (Prostate Cancer Foundation, University of California, Los Angeles) View the Transcript Below: From Bench to Business Bridging…

PANEL DISCUSSION: Luminaries in Prostate Cancer: How the Past Informs our FutureModerator: Phillip Koo (Prostate Cancer Foundation) Panelists:Maha Hussain (Northwestern University)Oliver Sartor (Tulane University)Cora Sternberg (Weill Cornell Medicine; New York-Presbyterian) View the Transcript Below: Luminaries in Prostate Cancer: How the…

Prostate Cancer Foundation, Pfizer Advance Prostate Cancer Care in Latin America Visiting Professorship program builds crucial capacity in regions in need Every year, prostate cancer is diagnosed in nearly 205,000 men in Latin America, and in some areas, up to…
Whether you’ve had prostate cancer and have been successfully treated for it, or you’re in treatment for advanced disease… don’t forget about the rest of your body, especially, your heart. Good news: there’s a lot you can do to power…


To date, the 19th Hole Classic has raised over $150,000 for the Prostate Cancer Foundation, with the COT dedicated to driving out prostate cancer, one wicked drive at a time.

We are so excited to partner with Man Cave Health, Pocono Raceway and the Lehigh Valley Health Network, to continue to encourage men to know their PSA score.

Medical oncologist Alicia Morgans, MD, MPH, Medical Director of the Survivorship Program at Dana Farber, hosts a discussion with her team members: nurse practitioner Stacy Walker, CNP, and social worker Max McMahon, LICSW. Learn who’s on your team, and how…
Impact of Genetic Ancestry and DNA Methylation on Prostate Cancer in African and African American Patients Principal Investigator: Brian Joyce, PhD (Northwestern University) Young Investigators: Zequn Sun, PhD (Northwestern University) Co-Investigators: Adam Murphy, MD (Northwestern University), Mamoudou Maiga, MD, PhD (Northwestern University), Lifang…
Jeffrey Tosoian, MD University of Michigan Mentors: Arul Chinnaiyan, MD, PhD; Todd Morgan, MD; Bruce Trock, PhD Refinement, Validation and Clinical Application of a Novel Panel of High-Grade-Cancer-Specific Biomarkers in the Overall and African American Populations Description: What this means to…
In honor of veterans this month, we reflect on the remarkable advancements in prostate cancer care made possible by the tireless work of providers and researchers through the PCF-VA partnership across the U.S., and by the generous support of donors. …
The PSA screening test for prostate cancer has been used for decades, but it’s not a perfect test. Doctors don’t yet have an optimal way to identify upfront which men are at lower risk of aggressive prostate cancer and which men are at higher risk and might need earlier and/or…

Learn about key risk factors for diagnosis of prostate cancer that everyone needs to be aware of, and about the genetic connections that your family members need to know about, if you’re living with the disease. Urologist Dr. Samuel Washington III, MD, MAS,…


Business leader, entrepreneur and philanthropist Robert F. Smith is an avid supporter of the Prostate Cancer Foundation (PCF). His philanthropic efforts have helped advance critical research and development in early detection of prostate cancer. For example, the Robert Frederick Smith…

Panel: State of Science on Diet and Lifestyle in Lethal Prostate Cancer and Survivorship29th Annual PCF Scientific Retreat: October 27, 2022 | 2:55 PM – 3:55 PM Moderator: Lorelei Mucci, ScDHarvard TH Chan School of Public Health Panelists:William Aronson, MDUniversity…
FOR IMMEDIATE RELEASE: 2/20/25 CONTACT: Max Strauss or Ciara Smith, Atlanta Hawks Brand Communications, [email protected] ATLANTA – Prior to tonight’s game, the Atlanta Hawks Foundation, together with the Ressler Gertz Family Foundation, announced a $150,000 donation to the Prostate Cancer Foundation (PCF) to increase awareness…

Closing Remarks 2:30 PM – 2:35 PM Howard Soule, PhD Prostate Cancer Foundation Jonathan W. Simons, MD Prostate Cancer Foundation

Session 7: Recent Advances in Antibody-Drug Conjugates for the Treatment of Cancer 1:20 PM – 2:30 PM Moderator: Marco Gottardis, PhD Janssen Research & Development, LLC Introduction Marco Gottardis, PhD Janssen Research & Development, LLC Antibody Drug Conjugates: From Early Stage Research to Clinically Approved Drugs Peter…

Session 6: Advances for Immunotherapy in Prostate Cancer 12:20 PM – 1:15 PM Moderator: Howard Soule, PhD Prostate Cancer Foundation Introduction Howard Soule, PhD Prostate Cancer Foundation Clinical Development of PSCA-Targeted CAR T Cells for Advanced Prostate Cancer Tanya Dorff, MD City of Hope Co-expression of a Novel…

SPECIAL LECTURE 11:50 AM – 12:15 PM A Polygenic Risk Score for Predicting Prostate Cancer in Men of African Descent Christopher Haiman, ScD Center for Genetic Epidemiology and Norris Comprehensive Cancer Center, University of Southern California Introduced by Howard Soule, PhD Prostate…

SPECIAL LECTURE 11:35 AM – 11:50 AM VA-PCF Collaboration: Streamlined Genetic Sequencing in Veterans for Improved Clinical Care and Research Opportunities Julie Graff, MD VA Portland Health Care System Introduced by Rebecca Levine Prostate Cancer Foundation

SPECIAL LECTURE 10:55 AM – 11:30 AM State of the Science 2020 Jonathan W. Simons, MD Prostate Cancer Foundation Introduced by Howard Soule, PhD Prostate Cancer Foundation 11:30 AM – 11:35 AM Please Return to the Virtual Lobby to Join the Next Session

Session 5: Microbiome and Cancer 9:25 AM – 10:25 AM Moderator: Ellen Filvaroff, PhD Bristol Myers Squibb Introduction Ellen Filvaroff, PhD Bristol Myers Squibb The Plasticity of the Microbiome in Colorectal Cancer Christian Jobin, PhD University of Florida Host-Microbiome Interactions in Human Cancer Ran Blekhman, PhD University…

Session 4: Late Breaking Clinical Data for Prostate Cancer Patients 8:05 AM – 9:20 AM Moderators: Howard Soule, PhD Prostate Cancer Foundation Introduction Howard Soule, PhD Prostate Cancer Foundation Combinatorial Targeting of AR and AKT with Abiraterone and Ipatasertib for mCRPC with and without…

PANEL DISCUSSION: Prostate Cancer Disparities: Lessons from the COVID-19 Era 7:00 AM – 8:00 AM Moderator: Brandon Mahal, MD University of Miami Panelists: Erin Kobetz, PhD, MPH (University of Miami) Monica Baskin, PhD (University of Alabama at Birmingham) Thomas Farrington (Prostate Health Education Network) Randy Vince Jr.,…

PCF Press : Highlights from Day 1 and Look Forward at Day 2 2:35 PM – 2:45 PM Karen Knudsen, PhD Thomas Jefferson University

SPECIAL LECTURE 2:05 PM – 2:35 PM Current Challenges in Treatment of Patients with Metastatic Prostate Cancer Himisha Beltran, MD Harvard: Dana Farber Cancer Institute Introduced by Rana McKay, MD University of California, San Diego Live Discussion PCF Press : Highlights from Day…

Session 3: The PCF-ONE (PCF-One-on-one Networking & Engagement) Initiative 9:05 AM – 9:10 AM Ayesha Shafi, PhD Thomas Jefferson University Sarah Amend, PhD Johns Hopkins University Introduced by Andrea Miyahira, PhD Prostate Cancer Foundation 9:10 AM – 9:15 AM Please Return to the…

DEBATE: Prostate Cancer Genomic Classifiers; Are We Ready for Prime Time? 11:55 AM – 12:40 PM Moderators: Felix Feng, MD (University of California, San Francisco) Rana McKay, MD (University of California, San Diego) Speakers: Pro: Daniel Spratt, MD (University of Michigan) Con: Daniel Lin,…

SPECIAL LECTURE 9:53 AM – 10:15 AM The Genomic Evolution of Prostate Cancer Paul Boutros, PhD, MBA University of California, Los Angeles Introduced by Howard Soule, PhD Prostate Cancer Foundation Live Discussion

SPECIAL LECTURE 9:38 AM – 9:53 AM A Community Resource of Genetically-Engineered Mouse Models that Recapitulate the Phenotypic Spectrum of Prostate Cancer Cory Abate-Shen, PhD Columbia University Irving Medical Center Live Discussion

SPECIAL LECTURE 9:15 AM – 9:38 AM Dual Functions of SPOP and ERG Dictate Androgen Therapy Responses in Prostate Cancer Jean-Philippe Theurillat, MD Institute of Oncology Research, Switzerland Introduced by Prof. Mark Rubin, MD University of Bern, Switzerland Live Discussion

Session 2: Circulating DNA Methylation Biomarkers for Diagnosis, Prognosis and Treatment Selection 8:10 AM – 9:10 AM Moderator: Gerhardt Attard, MD, PhD University College London Cancer Institute, UK Introduction Gerhardt Attard, MD, PhD University College London Cancer Institute, UK Using 5-hydroxymethylcytosine Sequencing to Interrogate Biological Drivers…

Session 1: Prostate Cancer, Androgens and COVID-19 7:05 AM – 8:05 AM Moderator: Nima Sharifi, MD Cleveland Clinic Introduction Nima Sharifi, MD Cleveland Clinic Regulation and Targeting of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2 in Human Airway Epithelial Cell Subtypes Arul Chinnaiyan, MD, PhD University…

Welcome and Opening Remarks 7:00 AM – 7:05 AM Howard Soule, PhD Prostate Cancer Foundation

Session 6: Closing Remarks and Introduction to Speed Networking Session 10:58 AM – 11:00 AM Howard Soule, PhD Prostate Cancer Foundation Andrea Miyahira, PhD Prostate Cancer Foundation 11:00 AM – 11:30 AM BREAK Please Return to the Virtual Lobby to Enter Speed Networking…

Session 5: Navigating Research and Careers in Challenging Times 10:10 AM – 10:58 AM Dinah Singer, PhD National Cancer Institute Introduced by William Dahut, MD National Cancer Institute Live Question and Answer Moderators: Howard Soule, PhD & Andrea Miyahira, PhD

Session 4: The Transition Path from Trainee to Faculty 9:15 AM – 10:05 AM Tanya Stoyanova, PhD Stanford University Introduced by Howard Soule, PhD Prostate Cancer Foundation Live Question and Answer Moderators: Howard Soule, PhD & Andrea Miyahira, PhD 10:05 AM – 10:10…

Session 3: The PCF-ONE (PCF-One-on-one Networking & Engagement) Initiative 9:05 AM – 9:10 AM Ayesha Shafi, PhD Thomas Jefferson University Sarah Amend, PhD Johns Hopkins University Introduced by Andrea Miyahira, PhD Prostate Cancer Foundation 9:10 AM – 9:15 AM Please Return to the…

Session 2: Cancer Research and Career Development during a Pandemic: Challenges, Lessons, Strategies and Opportunities 8:30 AM – 9:05 AM Ross Levine, MD Memorial Sloan Kettering Cancer Center Introduced by Howard Soule, PhD Prostate Cancer Foundation Live Question & Answer Moderators: Howard Soule,…

Welcome & Introduction 7:00 AM – 7:05 AM Howard Soule, PhD Prostate Cancer Foundation Andrea Miyahira, PhD Prostate Cancer Foundation Session 1 : Panel Discussion: Maintaining Research Productivity in the COVID Era: Perspectives from the YI Spectrum 7:05 AM – 8:25 AM Moderators: Sarah Amend,…

Session 6: Closing Remarks and Introduction to Breakout Networking Session 12:00 PM – 12:05 PM Sarah Amend, PhD (Johns Hopkins University) Claire Fletcher, PhD (Imperial College London) Ayesha Shafi, PhD (Thomas Jefferson University) 12:05 PM – 12:15 PM Please Return to the Virtual…

Session 5: PCF Women in Science “Above and Beyond” Award Presentation and Keynote Lecture 11:30 AM – 12:00 PM Introduction and Award Presentation Amina Zoubeidi, PhD (Vancouver Prostate Centre) Susan Halabi, PhD (Duke University) Beside Every Great Woman are Other Great Women Rachel…

Session 4: The Effects of the Pandemic on High School STEM Students 10:45 AM – 11:25 AM Introduction by Brandon Mahal, MD (University of Miami) Elisabeth Heath, MD (Karmanos Cancer Institute, Wayne State University) Brandon Contreras Teacher, Dominguez High School Giselle…

Session 3: Panel Discussion : Diversity & Inclusion in Cancer Research Leadership 8:50 AM – 10:15 AM Moderator: Karen Knudsen, MBA, PhD Executive Vice President of Oncology Services, Jefferson Health Enterprise Director, Sidney Kimmel Cancer Center, Thomas Jefferson University Panelists: Laurie Glimcher, MD President and…

Session 2: Keynote II: Adaptive Platform Trials: Scalable from Breast Cancer to COVID 7:55 AM – 8:45 AM Introduction by Himisha Beltran, MD (Harvard: Dana-Farber Cancer Institute) Laura Esserman, MD, MBA Professor, Departments of Surgery and Radiology, University of California, San Francisco; Director,…

Welcome, Introductions and Vision 7:00 AM – 7:05 AM Himisha Beltran, MD Harvard: Dana-Farber Cancer Institute Lorelei Mucci, ScD Harvard T.H. Chan School of Public Health Session 1: Keynote 1: Run Your Own Race, Always Remembering to Plant the Seeds of Triumph 7:05 AM – 7:50…

Closing Remarks Friday, November 5, 2021 | 12:15 PM – 12:20 PM PST Speaker(s): Howard Soule, PhD, Prostate Cancer Foundation Andrea Miyahira, PhD, Prostate Cancer Foundation

Session 11: Novel Technologies to Overcome the Suppressive Tumor Microenvironment Friday, November 5, 2021 | 10:50 AM – 12:15 PM PST Moderator: Marco Gottardis, PhD, Janssen Research & Development, LLC Introduction Marco Gottardis, PhD, Janssen Research & Development, LLC Improving CAR Responses…

Session 10: Widening the Aperture; New Approaches for Immunotherapy in Prostate Cancer Friday, November 5, 2021 | 8:50 AM – 10:35 AM PST Moderator: Amy Moran, PhD, Oregon Health & Science University A T Cell Intrinsic Role for Androgen Receptor Signaling…

SPECIAL LECTURE: Massimo Loda, MD Friday, November 5, 2021 | 8:00 AM – 8:35 AM PST SPECIAL LECTURE: Tumor Metabolism as a Driver and Treatment Target in Prostate Cancer Massimo Loda, MD, Weill Cornell Medicine Introduced and moderated by Howard Soule,…

Session 9: Real World Evidence and Synthetic/Virtual Control Arms Friday, November 5, 2021 | 7:00 AM – 8:00 AM PST Moderator: Julie Lynch, PhD, RN, MBA, VINCI Precision Medicine, Salt Lake City VA & University of Utah Opportunities and Pitfalls of…

Session 8: Glucocorticoid Receptor Biology in Castration Resistant Prostate Cancer Thursday, November 4, 2021 | 11:45 AM – 12:45 PM PST Moderator: Nima Sharifi, MD, Cleveland Clinic Acquired Defects in Glucocorticoid Metabolism in Enzalutamide-Resistant Prostate Cancer Nima Sharifi, MD, Cleveland Clinic Targeting…

SPECIAL LECTURE: PCF 3.0: Charles Ryan, MD Thursday, November 4, 2021 | 11:05 AM – 11:45 AM PST SPECIAL LECTURE: PCF 3.0: Serving the Science, the Scientist and the Patient Charles Ryan, MD, Prostate Cancer Foundation Introduced and moderated by Howard…

SPECIAL LECTURE: Oncology: A Storied Past and Portentous Future 28th Annual PCF Scientific Retreat: November 4, 2021 | 10:25 AM – 11:00 AM Anna Barker, PhD Lawrence J. Ellison Institute for Transformative Medicine of the University of Southern California Introduced and moderated by Howard Soule,…

KEYNOTE ADDRESS: Michael Milken Thursday, November 4, 2021 | 9:10 AM – 10:10 AM PST Michael Milken, Founder and Chairman, Prostate Cancer Foundation Introduced by Stuart Holden, MD, Prostate Cancer Foundation

PCF WOMEN IN SCIENCE AWARD LECTURE: Karen Knudsen, MBA, PhD Thursday, November 4, 2021 | 8:25 AM – 9:10 AM PST PCF WOMEN IN SCIENCE AWARD LECTURE: Tumor Suppressors Reimagined: Converting Understanding of RB Action into Translational Potential Karen Knudsen, MBA,…

Session 7: Next Generation Precision Medicine Thursday, November 4, 2021 | 7:00 AM – 8:10 AM PST Moderator: Felix Feng, MD, University of California, San Francisco A Multi-Omic Perspective on mCRPC Felix Feng, MD, University of California, San Francisco Using Genomics and…

Session 6: Predicting Risk of Prostate Cancer with Polygenic Scores Friday, October 29, 2021 | 11:20 AM – 12:20 PM PST Moderator: Tyler Seibert, MD, PhD, University of California, San Diego Genetic Risk Prediction for Prostate Cancer Christopher Haiman, ScD, University of…

Special Lecture: ADT and CV Risk: Why Relugolix? 28th Annual PCF Scientific Retreat: October 29, 2021 | 10:45 AM – 11:05 AM Neal Shore, MD Carolina Urologic Research Center GenesisCare, US Introduced and Moderated by Howard Soule, PhD

Session 5: Prostate Cancer Survivorship Friday, October 29, 2021 | 8:55 AM – 10:45 AM PST Moderator: Alicia Morgans, MD, MPH, Harvard: Dana-Farber Cancer Institute Prostate Cancer Survivorship: New Programs and Strategies Alicia Morgans, MD, MPH, Harvard: Dana-Farber Cancer Institute Updates and…

Session 4: Prostate Cancer Disparities Friday, October 29, 2021 | 7:00 AM – 8:40 AM PST Moderator: Kosj Yamoah, MD, PhD, Moffitt Cancer Center Overview on Prostate Cancer Disparities in African Americans: Lessons from the VA Health System and VANDAAM Study Kosj…

PCF Doctor-Patient Summit Thursday, October 28, 2021 | 1:00 PM – 3:00 PM PST The Doctor-Patient Summit is a special two-hour virtual event for patients, caregivers, and loved ones. The Summit kicks off with two moderated hot-topic sessions. In the second…

Session 3: PSMA Theranostics: The New Age of Prostate Cancer Imaging and Treatment Thursday, October 28, 2021 | 9:40 AM – 12:00 PM PST Moderator: Michael Hofman, MBBS, Peter MacCallum Cancer Centre; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProSTIC), Australia …

Session 2: Therapeutic Degraders as New Class of Prostate Cancer Treatments Thursday, October 28, 2021 | 8:45 AM – 9:25 AM PST Moderator: Howard Soule, PhD, Prostate Cancer Foundation Targeting Enhancer Addiction in Prostate Cancer by Impeding Chromatin Accessibility Arul M. Chinnaiyan,…

Session 1: Dr. Andrew Hruszkewycz Memorial Session on Measuring and Targeting Lineage Plasticity to Prevent Lethal Prostate Cancer Thursday, October 28, 2021 | 7:04 AM – 8:30 AM PST Moderator: Andrew Armstrong, MD, ScM, Duke University A Tale of Two Evasions: Lineage…

Welcome & Opening Remarks 28th Annual PCF Scientific Retreat: October 28, 2021 | 7:00 AM – 7:04 AM Howard Soule, PhD Prostate Cancer Foundation

Session 5: Update on the PCF-ONE Virtual Mentoring Initiative PCF Young Investigator Forum: October 22, 2021 11:00 AM – 11:15 AM Ayesha Shafi, PhD Center for Prostate Disease Research (CPDR); USU Walter Reed Surgery Sarah Amend, PhD Johns Hopkins University Introduced by Andrea Miyahira, PhD Prostate…

Session 4: Panel: Where Do Clinical Trials Come From PCF Young Investigator Forum: October 22, 2021 9:45 AM – 10:45 AM Moderator: Atish Choudhury, MD, PhD Dana Farber Cancer Institute Panelists: Maha Hussain, MD Northwestern University S. Percy Ivy, MD Cancer Therapy Evaluation Program (CTEP), National Cancer…

Session 3: Panel: Science Careers in the Age of the Pandemic and Zoom PCF Young Investigator Forum: October 22, 2021 | 8:15 AM – 9:30 AM Moderators: Howard Soule, PhD Prostate Cancer Foundation Andrea Miyahira, PhD Prostate Cancer Foundation Panelists: Leigh Ellis, PhD Cedars-Sinai Medical Center Jessica Hawley, MD University…

Session 2: Things I Learned During My Scientific Journey PCF Young Investigator Forum: October 22, 2021 | 7:15 AM – 8:00 AM Amina Zoubeidi, PhD Vancouver Prostate Centre Introduced by Howard Soule, PhD Prostate Cancer Foundation Live Question & Answer Moderators: Howard Soule, PhD & Andrea Miyahira,…

Session 1: Welcome & Introduction PCF Young Investigator Forum: October 22, 2021 | 7:00 AM – 7:15 AM Howard Soule, PhD Prostate Cancer Foundation Andrea Miyahira, PhD Prostate Cancer Foundation

Session 5: Closing Remarks and Introduction to Breakout Networking Session PCF Women in Science Forum: October 21, 2021 | 12:10 PM – 12:15 PM Himisha Beltran, MD Harvard: Dana-Farber Cancer Institute Andrea Miyahira, PhD Prostate Cancer Foundation

Session 4: Panel: Honest Discussion: Challenges That We don’t Talk About PCF Women in Science Forum: October 21, 2021 | 11:15 AM – 12:10 PM Moderators: Susan Halabi, PhD Duke University Eileen Parkes, MD, PhD University of Oxford Panelists: Claire Fletcher, PhD Imperial College London Janielle Maynard, PhD The Johns…

Session 3: Panel: High School Students in Research and Mentoring October 21, 2021 | 10:15 AM – 11:00 AM Moderator: Elisabeth Heath, MD Karmanos Cancer Institute, Wayne State University Panelists: Lorelei Mucci, ScD Harvard T.H. Chan School of Public Health Amina Zoubeidi, PhD Vancouver Prostate Centre Precious Amuwha FocuSStem…

Session 2: Panel: Celebration of Achievements of Women in Prostate Cancer Oncology and Research PCF Women in Science Forum: October 21, 2021 | 8:20 AM – 10:00 AM Moderators: Karen Knudsen, MBA, PhD American Cancer Society Dana Rathkopf, MD Memorial Sloan Kettering Cancer Center Panelists: Remi Adelaiye-Ogala,…

Session 1: Keynote: Personal Perspectives on Women in Research & Academic Leadership October 21, 2021 | 7:05 AM – 8:05 AM Introduction by Karen Knudsen, MBA, PhD (American Cancer Society) Vivian Pinn, MD Senior Scientist Emerita, Fogarty International Center, NIH Former Director (Retired), Office of…

Welcome, Introductions and Vision PCF Women in Science Forum: October 21, 2021 | 7:00 AM – 7:05 AM Sarah Amend, PhD Johns Hopkins University Salma Kaochar, PhD Baylor College of Medicine

Closing Remarks 29th Annual PCF Scientific Retreat: October 29, 2022 | 11:45 AM – 12:00 PM Howard Soule, PhD Prostate Cancer Foundation Andrea Miyahira, PhD Prostate Cancer Foundation

Session 11: Novel Gamma Delta T Cell Therapy Platforms for Oncology 29th Annual PCF Scientific Retreat: October 29, 2022 | 10:00 AM – 11:45 AM Moderator: Marco Gottardis, PhD Janssen Research & Development, LLC Introduction Marco Gottardis, PhD Janssen Research & Development, LLC Primer…